While ATM mutations are generally associated with a 25-30% lifetime risk for breast cancer, emerging information suggests that the risk in those with a c.7570G>C mutation may be higher. Once confirmed, this information may be important to guide cancer screening and risk-reducing surgery decisions.
Use this link to learn more: https://onlinelibrary.wiley.com/doi/10.1002/ijc.34305